This trial will focus on understanding how well a Best Practice Advisory for high-intensity statin therapy works in patients with Peripheral Artery Disease.
- Peripheral Arterial Disease
2 Primary · 1 Secondary · Reporting Duration: Baseline, upon patient discharge through study completion, average of six months
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
150 Total Participants · 2 Treatment Groups
Primary Treatment: Best Practice Advisory · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any open slots remaining in this study?
"Affirmative. The clinicaltrials.gov repository confirms that this medical trial began recruiting on April 20th 2022, and has since been edited November 8th of the same year. A total of 150 participants are sought from a single site for enrollment." - Anonymous Online Contributor
How many candidates has this trial been able to accept thus far?
"Correct. Based on the clinicaltrials.gov database, this ongoing medical trial was first posted on April 20th 2022 and is currently recruiting 150 individuals from a single research site." - Anonymous Online Contributor